Swiss medical data specialist Sophia Genetics today announced the closing of a $110 million financing round to enter into the next stage of its expansion.
The Series F round was led by aMoon, a health tech and life sciences venture fund based in Israel, and Hitachi Ventures, a venture arm of Japanese Hitachi Group. The company also received the trust of prime financial institutions Credit Suisse...
